John Nicholson, SVP & Chief Financial Officer at NEKTAR THERAPEUTICS (NKTR), sold 319,884 shares at $10.99 ($3.4M) on 2015-08-11, disclosed to the SEC on 2015-08-13.
Scheduled sale ($3.4M) by SVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.67 | 95,000 | $1.0M | 29.4% |
| 2 | $10.99 | 154,908 | $1.7M | 49.4% |
| 3 | $10.47 | 66,000 | $691K | 20.0% |
| 4 | $10.64 | 3,976 | $42K | 1.2% |
| Total | $10.78 avg | 319,884 | $3.4M | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |